Abnormal prion protein (PrP Sc ) generated from the cellular isoform of PrP (PrP C
the innate immune system has been suggested to partially block the progression of TSE; 34 however, the mechanism is not well understood. To further elucidate the role of the 35 innate immune system in prion infection, we investigated the function of interferon 36 regulatory factor 3 (IRF3), a key transcription factor of the MyD88-independent type I 37 interferon (IFN) production pathway. We found that IRF3-deficient mice exhibited 38 significantly earlier onset with three murine TSE strains, namely, 22L, FK-1, and mBSE 39 following intraperitoneal transmission, when compared with wild-type controls. it is suggested that blockade of TLR4 signaling pathway accelerates the progression of 82 TSE. Nonetheless, the effects of the innate immune system on prion infection remain 83 controversial and have not been fully clarified. 84
We focus on interferon regulatory factor 3 (IRF3), which is a key transcription 85 factor of the MyD88-independent pathway that has an essential role in the type I IFN 86 response to microbial infection, and whose deficiency in mice leads to susceptibility to 87 many viruses (19) . In this study, we investigated the role of IRF3 in prion infection 88 using IRF3-deficient mice and prion-susceptible cell lines. 89
90

RESULTS
91
Prion infection is accelerated in IRF3-deficient mice. 92
To clarify the significance of IRF3-dependent signaling pathways in prion infection in 93 vivo, we peripherally inoculated 22L strain into IRF3-gene knockout mice (IRF3-/-) 94 (33) and control wild-type (C57BL/6) mice. When the mice were challenged with 10 -3 95 dilution of 22L inoculum by the intraperitoneal (i.p.) route, the IRF3-/-mice showed 96 significantly abbreviated survival periods (257 ± 8 days, p < 0.001) compared with 97 those of the control mice (281 ± 15 days) (Table 1 and Fig. 1A ). To further investigate 98 the protective effect of IRF3 on prion infection, the mice were challenged with 10 -3 99 dilution of mouse-adapted BSE (mBSE) or Fukuoka 1 (FK-1) strain by the i.p. route. 100 IRF3-/-mice showed shorter survival periods of mBSE (335 ± 37 versus 380 ± 33 days, 101 p < 0.05), and FK-1 (251 ± 31 versus 321 ± 24 days, p < 0.01) compared with control 102 mice ( Table 1 ). The shortening of survival periods in the IRF3-/-mice is unlikely to be 103 PrP-immunostaining (Fig. 1C) . Because spongiform changes and gliosis are common 114 characteristics of prion diseases, brain sections including the cerebral cortex (Cx), 115 hippocampus (Hi), thalamus (TH), cerebellum (CE), and pons (Po) from 22L-inoculated 116 mice were examined by histologically and subjected to immunohistochemical analysis 117 using anti-Iba-1 antibodies for microgliosis (Fig. 3A) or ant-GFAP for astrogliosis (Fig.  118   3B) . The severity and distribution of vacuolation and glial activation in the IRF3-/-mice 119 at 32 w.p.i. were indistinguishable from those in the wild-type mice at 40 w.p.i. (Fig 2  120 and 3), while IRF3-/-mice displayed significantly increased vacuolation (Fig. 2) and 121 astrogliosis (Fig. 3B) in the Cx and CE at 25 w.p.i.. Collectively, these results suggest 122 that the progression of TSE following i.p. transmission is accelerated in IRF3-/-mice, 123 although genetic elimination of IRF3 does not affect the final neuropathological 124 outcome. Furthermore, as shown in Table 2 and Fig. 4A , the deposition of PrP Sc in the 125 white pulp region of the spleens from the IRF3-/-mice was detectable in 1/5 at 2 w.p.i., 126 4/5 at 5 w.p.i., and 5/5 at 8 w.p.i., whereas none of the wild-type mice was positive at 127 the same timepoints. These observations indicate that the rate of accumulation of PrP To investigate the effect of down-regulation of IRF3 in the 22L-N2a58 cells, 141 we performed knockdown experiments using small interfering RNAs (siRNA). IRF3 142 expression was significantly decreased by two types of siRNA against IRF3, whereas 143 β-actin expression, as the internal standard, was not changed (Fig. 5B) In the present study, we found that a genetic deficiency of IRF3 accelerates the 161 progression of TSE following i.p. transmission in mice and the accumulation rate of 162
PrP
Sc in the spleen is increased in the IRF3-/-mice. Furthermore, we demonstrated that 163 IRF3 has the inhibitory effect on the PrP Sc accumulation and the levels of IRF3 are 164 inversely correlated with resistance to prion infection in cell culture. 165 IRF-3 is known to be constitutively expressed in many tissues and cells (6, 22, 166 45). Indeed, we confirmed the expression of IRF3 in brains (data not shown) and the 167 N2a58 cells (Fig. 5) . Furthermore, not only glial cells but also neurons express most 168 innate immunity-related genes and produce type I IFN in response to virus infection 169 (11). Although the role of IRF3 in prion propagation into the CNS is still unclear, we 170 speculate that an absence of IRF-3 signaling leads to increased prion replication not 171 only in peripheral tissues but also in the CNS. It would be of great value to examine this 172 further using neuron-specific IRF3-disrupted mice or neuron-specific IRF3-expressing 173
mice. 174
It was reported, in prion infection, that genetic disturbance of TLR4 (36) or 175 IL-10 (41) leads to shorter incubation periods of prion infection. Since these, 176 respectively, are an upstream and a downstream factor of IRF3-mediated pathway, the 177 findings may be due in part to functional changes in the IRF3-mediated signaling. 
MATERIALS AND METHODS 232 233
Reagents and Antibodies 234
The anti-PrP polyclonal mouse antiserum (SS) has been described previously (5). M20 235 is an affinity purified goat polyclonal antibody recognizing the C-terminus of mouse 236 PrP (Santa Cruz Biotechnology, Inc., CA, USA). Anti-mouse IRF3 (Santa Cruz 237 Biotechnology) and anti-mouse phospho-IRF3 (Ser396) (Cell Signaling Technology, 238
The mouse neuroblastoma cell line N2a was purchased from the American Type Culture 246
Collection (ATCC CCL131), and N2a58 cells overexpressing mouse PrP prepared from 247
N2a were transfected with a plasmid carrying wild-type mouse prnp cDNA (PrP-a 248 genotype, codons 108L and 189T) (27). Prion infected cells, 22L-N2a58, were produced 249 as previously described (27). After limiting dilution, several PrP Sc , the protein concentration was adjusted to 10 mg/ml, and samples were 279 digested with 20 μg/ml of proteinase K (PK, Sigma) at 37 °C for 30 min, and boiled for 280 5 min with sodium dodecyl sulfate (SDS) loading buffer (50 mM Tris-HCl, pH 6.8, 281
containing 5% glycerol, 1.6% SDS, and 100 mM dithiothreitol) and subjected to 282 SDS-polyacrylamide gel electrophoresis. The proteins were transferred onto an 283
Immobilon-P membrane (Millipore, 
Histopathology and Immunohistochemical Staining 317
The spleen and brain tissues were fixed in 4% paraformaldehyde, and 5-μm paraffin 318 sections prepared on PLL coat slides with microtome. To measure vacuolation in brain, 319 the tissue sections were stained with hematoxylin and eosin (HE). In PrP Sc staining, 320 after deparaffinization and rehydration, the sections were pretreated by hydrated 321 autoclaving at 121 °C for 15 min in 1 or 1.2 mM hydrochloric acid (17), followed by 322 immersion in 90% formic acid for 5 min (25) to enhance PrP visualization, according to and then optimally titrated and diluted to 1:5000 and 1:500 (26, 32). The negative 328 control sections were incubated with normal mouse IgG1 and IgG2b serum (DAKO) 329 and then exposed to the primary antibodies overnight at room temperature. For 330 determining follicular dendritic cell population in the spleen, we used anti-FDC 331 antibody CNA.42 (DAKO) (31) and normal mouse IgM serum (DAKO) as a negative 332 control for primary antibodies, and Histofine mouse stain kit (Nichirei biosciences, Inc., 333 Jpn) for the secondary antibody. In glial staining, primary antibodies of anti-GFAP (glial 334 fibrillary acidic protein) (DAKO) for the detection of activated astrocyte, and anti-Iba-1 335 (WAKO, Japan) for activated microglia were used. The secondary antibodies were 336 Envision-mouse or rabbit HRP (DAKO) used at 1:200 for 1 h. Finally, the samples were 337 stained with 0.025% 3,3' diaminobenzidine (DAB, Dojindo Lab, Japan) to visualize the 338 reaction product, and counterstained with hematoxylin. The pattern of vacuolation, 339
PrP
Sc deposits and gliosis were examined in 5 areas, namely the cortex, hippocampus, 340 thalamus, cerebellum, and Pons. In semi-quantitative evaluation of spongiosis and 341 gliosis, lesion severity of vacuolation as spongiform degeneration was scored on a 0-5 342 scale (non-detectable, a few, mild, moderate, severe and status spongiosus). PrP Sc Microgliosis and astrogliosis were scored on a 0-3 scale (non-detectable, mild, 345 moderate and severe) and the values for each brain region were averaged. 346
347
Statistical analysis 348
The Student's t-test and Mann-Whitney U-test were used for comparison between two 349 groups, and the one-way ANOVA followed by the Tukey-Kramer test, for multiple 350
comparisons. The log rank test was used to analyze mortality of prion-infected mice. 351
The correlation between parameters was determined by simple regression analysis and 352 
